V&Co Beauty’s hair care line rolls out to major retailers
Drug Store News
MARCH 6, 2024
V&Co Beautyâs peptide-infused hair care line comes in four shampoo and conditioner optionsâWavy, Straight, Curly and Thickening.
V 
Unpacking Amgen v. Sanofi
BioPharm
AUGUST 31, 2023
Exploring the state of pharma patents following the Supreme Court’s Amgen v. Sanofi decision.
98 Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Organic Olivia intros Flora-V
Drug Store News
FEBRUARY 29, 2024
Flora-V is a probiotic that is formulated with super fruits and aids in supporting a healthy vaginal microbiome, the company said.
52 
How abortion access changed in the first year after Roe v. Wade, in 8 charts
STAT
JUNE 24, 2023
One year ago, the Supreme Court struck down Roe v. Wade in a landmark decision that would fundamentally change abortion access in America. Perhaps one of the most dramatic signs of that shift is in the patchwork legal landscape that has emerged as states have enacted laws banning or restricting abortions. Read the rest…
142 
Expert Discusses Pharmacist's Role in Contraception, What Reversal of Roe v. Wade Could Mean
Pharmacy Times
JUNE 29, 2022
Elizabeth Ruzzo, PhD, founder and CEO of Adyn, discusses the impact of the reversal of Roe v. Wade and how it will affect pharmacies.
132 
Risk adjusted net present value: What is the current valuation of Merck’s V-116?
Pharmaceutical Technology
FEBRUARY 5, 2024
V-116 is a conjugate vaccine commercialized by Merck, with a leading Pre-Registration program in Streptococcal Pneumonia.
Vaccines 75
75 Vaccines 75
75 
V&A Dundee erases mentions of opioid-linked Sackler family
The Guardian - Pharmaceutical Industry
SEPTEMBER 1, 2023
V&A has faced criticism for being slow to disassociate itself from benefactors with role in US opioid epidemic The V&A Dundee has become the latest UK museum to remove a reference to the money it received from the Sackler family amid continuing anger over its central role in the opioid epidemic in the US.
53 
Scepticism as Russia claims coronavirus vaccine breakthrough with Sputnik V
pharmaphorum
AUGUST 11, 2020
Russia has become the first country in the world to approve a coronavirus vaccine, amid scepticism from international experts who have been unable to review or verify clinical data from the jab called ‘Sputnik V’ According to press reports the vaccine has been tested on one of President Vladimir Putin’s daughters.
Vaccines 98
98 
In absence of Roe v. Wade, an abortion doctor dwells on all the patients she does not see
STAT
JUNE 23, 2023
Last year, just a few months after the Supreme Court’s reversal of Roe v. Wade ended the constitutional right to abortion in the United States, Christine Henneberg published a memoir on two simultaneous life-defining experiences: carrying her first pregnancy during her first year performing abortions.
95 
Opinion: How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra
STAT
JUNE 5, 2023
Since a Texas judge’s decision dropped earlier this spring, Braidwood v. Becerra has sent shudders down public health’s spine. Their legal claims challenge the U.S.
Insurance 91
91 Insurance 91
91 
Statements and Thoughts on Motion on Summary Judgement in PharmacyChecker v. NABP et al
Policy Prescription
APRIL 19, 2023
[This post relates to a case titled PharmacyChecker.com v. I disagree with the decision of the court in New York to grant the Defendants’ motion for summary judgment in the matter of PharmacyChecker.com v. The post Statements and Thoughts on Motion on Summary Judgement in PharmacyChecker v.
52 
Positive in vitro results for Imutex’s FLU-v
Pharma Times
OCTOBER 1, 2022
Data further supports the continued development of FLU-v as a broad-spectrum influenza vaccine
Vaccines 61
61 Vaccines 61
61 
Listen: FTC v. biotech, Pfizer’s kitchen sink, & Vertex’s future
STAT
DECEMBER 14, 2023
Is no one safe from the FTC? Has Pfizer bottomed out? And is biotech finally back? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.
93 
Examining the Impact of the Roe v Wade Decision on Medication Access
Drug Topics
DECEMBER 12, 2022
Investigators set out to evaluate how medication access for certain rheumatic conditions has changed since June 2022.
200 
UK faces “V-Day” and largest ever vaccination programme
pharmaphorum
DECEMBER 7, 2020
Tuesday has been dubbed “V-day” in the UK, when the first doses of Pfizer/BioNTech’s coronavirus vaccine will be distributed to the public outside of a clinical trial. The post UK faces “V-Day” and largest ever vaccination programme appeared first on. Feature image copyright BioNTech SE 2020, all rights reserved.
Vaccines 82
82 Vaccines 82
82 
Opinion: Brain drain, skills loss, and other unintended consequences of overturning Roe v. Wade
STAT
SEPTEMBER 21, 2023
Every day at the Kansas clinic where I perform abortions, I take care of pregnant people who have driven 10 hours or more across state lines for their procedures. They’re exhausted after moving mountains to get there: taking time off work, arranging child care, gathering funds.
144 
Reviv Global and V-Health hope digital passport will reopen Vegas
pharmaphorum
MARCH 5, 2021
Reviv Global and partner V-Health Passport are backing their technology to allow the hospitality industry to reopen safely in resorts such as Las Vegas. V-Health Passport makes use of the Code technology from VST Enterprises and was launched with the backing of Zara and Mike Tindall MBE in 2020 as a way of opening up the global economy.
Hospitals 52
52 
Pharmacists Are Key Access Point for Patients Amid Alabama Ruling on IVF
Pharmacy Times
FEBRUARY 28, 2024
In LePage v. Center for Reproductive Medicine, the Alabama Supreme Court ruled that “extrauterine embryos” are considered children, causing some infertility clinics to halt IVF processes.
139 
Queen V survey explores women’s feelings about their vagina
Drug Store News
MARCH 13, 2023
Queen V’s data reveals that over half of women (52%) said their first intimate health issue had a negative impact on their emotional health and well-being and 41% said it made them not want to leave the house.
98 
How Dobbs v Jackson Women’s Health Organization Decision Influenced Self-Management Medication Use
Pharmaceutical Commerce
APRIL 1, 2024
Cross-sectional study explores the impact of this monumental Supreme Court ruling.
101 
Early data shows Russia’s Sputnik V COVID-19 vaccine produces immune response
pharmaphorum
SEPTEMBER 7, 2020
A trial of Russia’s Sputnik V coronavirus vaccine has shown the jab produces an immune response, although the study was too small to produce conclusive findings, particularly on safety. The post Early data shows Russia’s Sputnik V COVID-19 vaccine produces immune response appeared first on.
Immunization 98
98 
Listen: The FTC v. Amgen, Sarepta’s future, & Galapagos’ turnaround
STAT
MAY 18, 2023
Does the FTC have it out for pharma? What does it take to make an RSV vaccine? And how do you say “setting cash on fire” in Dutch? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.
Vaccines 82
82 Vaccines 82
82 
Opinion: How ideas from ancient Greece like ‘a bun in the oven’ continue to affect reproductive health policy
STAT
MARCH 5, 2024
Supreme Court handed down its decision in Roe v. In Dobbs v. 22, 1973, the U.S. Wade, declaring a Texas law prohibiting abortion, and similar laws in other states, to be unconstitutional. Not quite 50 years later, on June 24, 2022, the Supreme Court overturned the Roe decision.
118 
Listen: Bancel v. Bernie, Sarepta’s FDA runaround, & Regeneron’s ever-growing blockbuster
STAT
MARCH 23, 2023
What would Jonas Salk say if he were here right now? How do you know when an ALS treatment is working? And what can pharma CEOs learn from Mr. Rogers? We cover all that and more this week on the 251st episode of “The Readout LOUD,” STAT’s biotech podcast.
FDA 91
91 FDA 91
91 
Listen: SVB’s long biotech shadow, pushy AI algorithms, & Icahn v. Illumina
STAT
MARCH 16, 2023
Is AI dictating patient care? What happens when your bank falls apart? And can Illumina endure some shareholder activism? We cover all that and more this week on the 250th episode of “The Readout LOUD,” STAT’s biotech podcast.
Patient Care 87
87 Patient Care 87
87 
ICYMI: PhRMA COO Lori Reilly Esq. speaks with Jacob Van Naarden about the future of cancer research
PhRMA
NOVEMBER 8, 2022
On November 3, PhRMA sponsored The Atlantic’s People v. Our health care ecosystem has made tremendous progress in the fight against cancer, with the cancer death rate falling 32% from its peak in 1991. Cancer event, hosting the session PhRMA Presents: The Future of Fighting Cancer. PhRMA’s COO Lori Reilly, Esq.,
208 
Hospitals largely keep quiet on maternal care since Dobbs, STAT survey finds
STAT
APRIL 22, 2024
The Supreme Court decision to overturn Roe v. Wade has transformed not just abortion access but maternal health care across the United States, causing physicians in states with restrictive laws to shift treatment of conditions including ectopic pregnancy and miscarriage.
Hospitals 143
143 Hospitals 143
143 
Opinion: Needed for reproductive justice and autonomy: women in design
STAT
APRIL 12, 2024
As a professor of biomedical design for the past 20 years, I have seen this trend increase in a seemingly exponential way since the Supreme Court’s Dobbs decision overturned Roe v. Wade, allowing states to ban abortion. Read the rest…
116 
Florida accounts for 8% of U.S. abortions. With a forthcoming ban, where will patients go?
STAT
APRIL 3, 2024
Supreme Court overturned Roe v. Most of those abortions were for Florida residents, but thousands also were performed on patients who came from nearby states that already restricted abortions after the U.S. Wade in 2022. Several reproductive health organizations said there simply isn’t the capacity elsewhere to see so many patients.
131 
SCOTUS to decide ‘fundamental change’ in biologics patents with fate of Amgen v. Sanofi
PharmaVoice
MARCH 28, 2023
The Supreme Court will now decide whether Amgen can protect Repatha as a whole class of drugs or whether Sanofi’s rival product Praluent can retain a place in the market.
98 
Following Supreme Court Reversal of Roe v. Wade, Some Patients Fear Limited Access to Methotrexate
Pharmacy Times
JULY 13, 2022
Some anti-abortion laws may lead to legal action against health care providers who prescribe or provide medications that can be used to induce abortions.
132 
Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA
STAT
JUNE 8, 2023
Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer’s disease treatments? And should lawyers be allowed to use thesauruses? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast.
FDA 79
79 FDA 79
79 
V-01 as a Sequential Booster Can Produce Good Protection against Omicron Latest Phase III Data of COVID-19 Vaccine by Livzon Pharma
Pharma Mirror
FEBRUARY 19, 2022
The post V-01 as a Sequential Booster Can Produce Good Protection against Omicron Latest Phase III Data of COVID-19 Vaccine by Livzon Pharma appeared first on Pharma Mirror Magazine.
Vaccines 52
52 Vaccines 52
52 
Expert Discusses Long-Term Implications of Roe V. Wade Decision for Pharmacists, Contraception Access
Pharmacy Times
JUNE 30, 2022
With many ambiguous policies, pharmacists should refer to their State Boards of Pharmacy for guidance and should consider HIPAA implications.
HIPAA 123
123 HIPAA 123
123 
2024 Outlook: Drug price negotiations, Braidwood highlights top legal cases to watch
Fierce Healthcare
DECEMBER 18, 2023
Legal experts indicated they will be paying close attention to lawsuits surrounding the Medicare drug price negotiation program and Braidwood v. Preventative services covered under the Affordable Care Act and the Medicare drug price negotiations program are two legal questions that will play out next year.
114 
SCOTUS’ abortion pill mifepristone case is really about the FDA
STAT
MARCH 25, 2024
Now, in the wake of Roe v. The agency in 2016 extended that approval to 10 weeks and in 2021 removed the in-person dispensing requirement, citing years of data showing the drug’s relative safety. Wade’s upheaval, both those later changes could be reversed after a Fifth Circuit Court of Appeals’ ruling.
FDA 132
132 
US supreme court abortion pill hearing: key takeaways
The Guardian - Pharmaceutical Industry
MARCH 26, 2024
The supreme court heard oral arguments on Tuesday in Alliance for Hippocratic Medicine v FDA, the first abortion case to reach the supreme court since it overturned Roe v Wade almost two years ago. Continue reading.
FDA 45
45 FDA 45
45 
When Dobbs forced one doctor to shutter his abortion clinic, he took his mission on the road
STAT
DECEMBER 14, 2023
Earlier that day, the 32-year-old doctor had received word that the Supreme Court had just handed down a consequential decision in Dobbs v. On June 24, 2022, Aaron Campbell turned away patients at his abortion clinic for the first time. Jackson, upending the constitutional right to an abortion in the U.S.
137 
AbbVie cues up filing for c-Met ADC in lung cancer
pharmaphorum
NOVEMBER 29, 2023
AbbVie is preparing to file for accelerated approval of telisotuzumab vedotin (Teliso-V) as a treatment for some patients with lung cancer after the drug hit the mark in a pivotal phase 2 trial.
101 
DEA’s Proposed Rules on Controlled Substances Prescribing via Telemedicine and Their Uncertain Impact on the Pharmacy Community
Pharmacy Times
APRIL 28, 2023
Proposed rules would permit a telehealth provider to prescribe only up to a 30-day supply of a Schedule III-V non-narcotic controlled substance or buprenorphine through telehealth without the patient first being evaluated in person by a provider.
Updates on 503A Compounding: Legal and Regulatory Developments
Pharmacy Times
APRIL 7, 2023
Part 1 of this 2-part series examines USP and revisions for sterile and nonsterile compounding, veterinary compounding, FDA inspections of 503A pharmacies, and the interstate distribution of compounded prescriptions post Wellness Pharmacy v.
Compounding 123
123 
Supreme Court will decide abortion pill access
STAT
DECEMBER 13, 2023
It will be the court’s first major abortion case since it overturned Roe v. WASHINGTON — The Supreme Court agreed Wednesday to take on whether Americans can access a commonly used abortion pill. Wade last year, giving jurisdiction over abortion laws back to the states.
FDA 113
113 FDA 113
113 
V&A drops financial ties with Sackler family over links with opioids
The Guardian - Pharmaceutical Industry
OCTOBER 2, 2022
London museum bows to years of pressure and removes signs bearing name of family associated with OxyContin crisis Campaigners calling for the name Sackler to be dropped from cultural landmarks are celebrating this weekend.
56 
After swell of biopharma outrage, Supreme Court takes up high-profile mifepristone case
Fierce Pharma
DECEMBER 13, 2023
After last year’s explosive ruling to overturn the historic abortion ruling reached in Roe v. Wade, abortion access is back up for debate in the Supreme Court. | The Supreme Court's final decision could have consequences beyond abortion access.
FDA 98
98 FDA 98
98 
Let's personalize your content